chrisvoncsefalvay/vaers-outcomes huggingface dataset:
PASSED AFTER TAKING THE VACCINE; This spontaneous report received from a consumer via social media via a company representative concerned a male of unspecified age, race and ethnic origin. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (Janssen series 1) (suspension for injection, route of admin, and batch number were not reported) dose, 1 total, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date reporter stated that "I never thought that seeing an ad for something would have me crying so violently this early in the morning. Earlier this year one of my close friends passed after taking the J and J vaccine. I was displaced after his passing and it has ruined me financially. I haven't been able to recover and it seems I'm close to a grippy socks vacation over all of this. I wish you would have care more J and J. I wish friend was still alive." On 2021, the patient died from unspecified cause of death. It was unspecified if an autopsy was performed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. This report was serious (Death).; Sender's Comments: V0: 20211218656 -covid-19 vaccine ad26.cov2.s- passed after taking the vaccine. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).; Reported Cause(s) of Death: UNSPECIFIED CAUSE OF DEATH
Fever for 15 hours >99.8 to max 102.5; Chills intermittently for 1 day; Headache throbbing 1 day; This is a spontaneous report from a contactable other health care professional (patient herself).  A 25-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; formulation solution for injection; Lot number was not reported), via unspecified route of administration, on 08Jan2021, and second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; formulation solution for injection; Lot number: EL3246), via unspecified route of administration, on 28Jan2021 (in left arm); both doses given at single dose, for Covid-19 immunization. The patient did not have covid prior to vaccination and had no allergies. The patient's medical history included oral contraceptive. The patient's concomitant medications included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL) at dose of 5 mg and piroxicam (PAXIL [PIROXICAM]) taken as oral contraceptive at dose of 30 mg OCP (oral contraceptive). On 29Jan2021 03:00 AM, the patient experienced fever for 15 hours >99.8 to max 102.5, chills intermittently for 1 day, and headache throbbing for 1 day. The patient did not receive any treatment for the events. The outcome of the event was considered as resolving.  Follow-up attempts are completed. No further information is expected.
No adverse event; HCP stated they had 12 patients from 6 months to 5 years not previously vaccinated, and accidentally they administered 2 doses 1 month apart (0.25 mL); This spontaneous case was reported by an other health care professional and describes the occurrence of WRONG PRODUCT ADMINISTERED (HCP stated they had 12 patients from 6 months to 5 years not previously vaccinated, and accidentally they administered 2 doses 1 month apart (0.25 mL)) and NO ADVERSE EVENT (No adverse event) in an 11-month-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 216K22A) for COVID-19 prophylaxis.     Patient's relevant medical history/conditions, allergy, concomitant diseases and risk factor were unknown.    On 29-Jun-2023, the patient received first dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On 27-Jul-2023, received second dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) dosage was changed to .25 milliliter. On 27-Jul-2023,  after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced WRONG PRODUCT ADMINISTERED (HCP stated they had 12 patients from 6 months to 5 years not previously vaccinated, and accidentally they administered 2 doses 1 month apart (0.25 mL)). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (HCP stated they had 12 patients from 6 months to 5 years not previously vaccinated, and accidentally they administered 2 doses 1 month apart (0.25 mL)) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (HCP stated they had 12 patients from 6 months to 5 years not previously vaccinated, and accidentally they administered 2 doses 1 month apart (0.25 mL)).    Patient did not received any other vaccines in the 4 weeks prior to COVID-19 vaccine. Concomitant medication details not reported by the reporter. Treatment details was not reported by the reporter. This case contains information about 6th patient out of 12.   This case was linked to US-MODERNATX, INC.-MOD-2023-737355 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-737355:Master case
According to phone call received vaccine expired 5/11/2023 and was administered on 5/12/2023.  No email received with update regarding expiration of this vaccination. Vaccination was ordered for administration starting in September 2022 which is less than 1 year.
On 4/14/21 patient noted redness and swelling in his right arm, lower bicep area, closer to the elbow.  Redness is ~ 5x3 inches.  Area of induration is the size of a quarter.  C/O itching.  Denies any obvious bug bite.  Called his physician, who reported to him that it could be "Moderna arm" or bug bite.  Unsure about "Moderna arm" due to 2 months since last shot.  Starting on steroids.  If worsens, will treat with antibiotics.
Pt presented 4/25 w/ redness and moderate hardness/swelling of arm (approx 2" c 1.5" in surface area. She said it occurred after vaccine. She used BENADRYL every 4 hours and ice pack which helped for 4 days. Advised pt on 5th day (on 4/25) to also add MOTRIN. Followed up w/pt again on 4/26 and she said it is almost resolved and he arm is doing better.
patient presented to ED on 8/24/21 with malaise and fever. Patient was fully vaccinated and got tested positive for covid on 9/21. Patient was treated appropriately for covid and was discharged on 8/31/21.
Patient received the Covid 19 vaccine on 12/22/2020. Four days after vaccination (12/26/20) she started to notice that  she "loss her sense of smell "while brushing her teeth. The toothpaste tasted "weird". All of the sudden, she lost her appetite. These symptoms persist today.  Covid test scheduled on 12/28/2020 at Employee Health.
Information has been received from a registered nurse concerning a 17 year old female patient who on an unspecified date was vaccinated with a second dose of GARDASIL (Lot # not provided). Subsequently the patient experienced deltoid muscle atrophy. At the time of the report, the patient's deltoid muscle atrophy persisted. The patient sought unspecified medical attention. Follow up information has been received from a nurse practitioner who stated that a 13 year old female student was vaccinated IM with a second dose of GARDASIL (Lot # 665547/1318Y) in the right deltoid. Additional information has been requested.
No adverse affects reported, patient under the age of 18 and was administered a Moderna vaccine.
few days after i got the first shot i started itching every where in my body, then i saw i had a rash all over my body and it got worse every day that i had to go to the emergency room, full of red patches all over,  at the emergency room gave me some steroids and take Benadryl at home and go see a dermatologist cause it was probably a skin issue.  then the 2nd shot came and i got worse,  i feel like ripping my skin off and i'm full of scratches from scratching myself. i wont go to the urgent care again because i paid 100 copay for nothing.  i'm just using calamine lotion and taking Benadryl at night.....    If i knew this i would have NOT get the shot,,,,, i had covid anyways so i should have my antibodies anyways.   I REGRET GETTING THE SHOT
Vomiting, high fever of 102 deg. f. and complete lethargy.
Had a pfizer booster shot on 8/21/21 and the next day both heels have been sore. Extreme sore heels since it's been almost a month.
On 10/03/2000, it was reported the patient "presented with no fever and 15 chickenpox lesions". Initially it had been reported that the patient sought medical attention, however follow up information indicated that the patient's experience did not require a doctor visit. The outcome of the patient's experience was not reported. No additional information is expected.
This case was reported by a nurse via sales rep and described the occurrence of nodule on extremity in a 2-month-old patients who received PEDIARIX. On an unknown date, the patients received PEDIARIX at an unknown dose. On an unknown date, an unknown time after receiving PEDIARIX, the patients experienced nodule on extremity to be related to PEDIARIX. Additional details were provided as follows: This case was previously reported to a doctor. The reporter stated that, many patients had experienced leg nodules after receiving the PEDIARIX vaccine which had lasted for a long time. The parents of the patient called to report that their babies had a know in their legs and it was not going away. The reporter felt that it was due to the PEDIARIX vaccine. The complaints appear to have occurred after the patient's 2 months check-ups. The reporter did not have any patient information at the time of the call but she was actively collecting the information to provide when she was contacted by GlaxoSmithKline. The reporter stated that, the adverse event had nothing to do with technique because several different nurses administered the product with the same results. This case was reported to the sales representative during a lunch in-service in which the physician, nurse and practice manager were all present. The Medical Science Liaison was contacted and talked with the nurse and practice manager during the meeting. On 19th July 2016, the sales representative did try to contact the GSK response centre to report the adverse event, by the GSK Response Centre was close for several hours due to technical issues. The reporter was unable to provide any further details.
67 y/o female with past medical history of Migraines and Hypertension who presents with dizziness post vaccination. Patient states that this is her second dose in the two-dose series. Patient states that she received her vaccination to the right arm. Patient states that with the first vaccination she did experience dizziness, nausea and migraines. Patient denies headache, vision changes, sore throat, difficulty swallowing, difficulty breathing or chest pain. Patient denies feeling nervous or anxious with vaccinations. Patient initial vitals with Hypertension noted, 197/112 BP, 78 HR, 98 % RA, 12 Resp. Patient instructed to lay on cot and water bottle provided. Patient vitals continuously monitored with persistent hypertension present (186/103, 223/118 BP) at this time the NP requested the Paramedics to obtain the BP manually. Patient BP manually taken every 5 minutes x2 with readings as follows, 150/96 and 138/80. Patient states that she is feeling better and dizziness has resolved. Patient placed in sitting position for 5 mins and then instructed to stand for 5 mins. Patient stable on her feet with no dizziness reported. Patient discharged in stable condition and ambulated without difficulty. Patient has a follow up appointment immediately with HCP post vaccination, today.
8 hrs later 99.7 temp , sweat body aches, dizziness 5/17 2am fever 100.7 fever chills severe headache, vomiting fly like symptoms,  stomach aches, could not stand no energy  finally 2pm 5/18 drove to urgent care as I could not go any further
It was reported that a 24 year old female received Fluzone SV 98-99 USP on 10/20/1998. Reportedly, that same day the pt experienced a rash on the right side of her face extending to neck. From additional information received on 11/20/98, it was reproted that the pt recovered from this experience.
I had a headache, congestion and aches all over my body. I had a terrible cough and a very runny nose. I completed a home test on November 28, 2022, and it was positive. I called my doctor, and she reviewed the symptoms. She prescribed PAXLOVID. I started the prescription on the same day. I had 2 really bad days, but they started to improve after that. I got progressively better. It took about 9 days to completely subside. I still have a cough and a little runny nose. It's not severe just annoying.
It was a hip pain going from my spine to my hip into the hip flexer muscle and I believe its ligament related . And I did nothing , I just woke up with this after my vaccine. It prevents me from going up and down stairs, pain upon rising and weakness in leg.
2 weeks after booster, developed severe itchiness and red-raised hives all over body.  Symptoms only relieved with antihistamines. Symptoms are still ongoing 1.5 weeks later.
Spots of blood and mucous in stool, since 12-27-14. Stool test positive for fecal occult blood (Hemoccult) in physician's office.
ON 6-17-2009, ONE DAY AFTER RECIEVING DTAP, MOTHER REPORTED MODERATE TO LARGE AMT. OF SWELLING AT INJECTION SITE. REDNESS, WARMTH, AND SWELLING FROM TOP OF ACRONIAN PROCESS EXTENDING TO THE ELBOW. TEMP 99.3. INSTRUCTED TO MONITOR AND REPORT TEMP GREATER THAN 100, DARKNESS OF ARM INCREASE SWELLING NUMBNESS OR TINGLING.
suspected vaccination failure; shingles; was sick; had painless bumps on it; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles, sickness and skin disorder. On an unknown date, the outcome of the vaccination failure, shingles, sickness and skin disorder were unknown.   It was unknown if the reporter considered the vaccination failure, shingles, sickness and skin disorder to be related to Shingles vaccine.  Additional details were provided as follows: The case was reported by patient. The age at vaccination was not reported. The patient got the shingles vaccine a few years ago. Ithe patient was sick and went to the physician for something else. The patient had painless bumps on it , and when asked , the physician  looked and said it was shingles. It was very light, painless case because the patient had the vaccine. This case was considered as suspected vaccination failure since the details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were not provided.
Spasm of pelvic area, weakness in legs, pt could not walk. She described it as a funny feeling. She was taken into the pharmacy area, sat down, and her blood pressure was recorded (140's/90's). She felt better almost immediately. She stated she does have hypertension, does not have diabetes or kidney problems. She was given water to drink. She sat for a while, then her husband picked her up.
Patient developed rash at the site of administration three days following administration. Rash was treated with oral diphenhydramine and VALTREX.
local swelling @ inject site; diffuse swelling & pain across shoulders & pain pharynx; weakness & difficulty of swallowing-no objective swallowing abn on clinical exam; persistent pain-both shoulders & upper mid thoracic area x 3-4 days;
Given . 5 cc instead of 1cc. Checked with provider and ok to bring pt back in for 1 cc of Hep B vaccine.
Tested positive for COVID-19 infection 14 or more days after being fully vaccinated. 1st dose: 02/28/2021 Pfizer, lot# EN6202; 2nd dose: 03/23/2021, Pfizer, lot# ER8727. Diagnosed COVID positive: 07/19/2021. Symptoms started:07/20/2021. Exposure: Community exposure. Symptoms: Fever; fatigue; muscle ache; loss of smell/taste.
dizziness and fever of 99.2, these symptoms lasted until 5/20/21 11:30am
Jan 05, 2021 : Dr.: Established Patient Video Consult :Video Consult Search Notes EditExportPrintReportsFaxRx1 of 1 Age29Visit TypeEstablished Patient Video Consult DateJan 05, 2021StatusUnsignedProviderDr. Signed by-- Subjective Chief Complaints Pfizer vaccine last Tuesday on Left arm.. 1.5 days later on opposite arm around elbow. Chief Complaint Rash History of Present Illness Location of symptoms: Generalized body, Chest, Abdomen, Upper Extremities, Right, Left Timing: Worsening  on prednisone and famotidine oral treatment
Bilateral leg pain, progressing to left hand weakness, then right hand weakness, then bilateral hand and forearm pain.  I went to emergency department 10/01/2011 and was evaluated.  I will be going to neurologist 10/03/2011 for evaluation.
Starting about 11PM, left arm from fingers up my arm to below my ear, across to my right shoulder ached, had chills, and could not get comfortable in bed.  Once up at 7 AM took two Advil 200mg with relief
Pt recvd Engerix-B on 17MAY90 & 3AUG90; Both times were uneventful; 19NOV90 pt recvd Engerix-B & exp elevated liver-enzymes, BP & pulse;
I have received both doses of the Pfizer vaccine-1st on 2/3/21, 2nd on 2/24/21. I have received two positive COVID tests-one PCR, one rapid-as of 4/1/21. I am symptomatic. The CDC recommended I contact VAERS to report as I have been vaccinated for over a month, have been risk mitigating and only working from home, and still contracted; I think they were concerned this could potentially be a variant.
Thursday, January 12, 2023, I had allergy symptoms with sneezing and cough and itchy throat.  Friday it was about the same.  Saturday, I worked outside for about 10 hours and when I went in and showered, I just felt awful.  I took Tylenol and Mucinex.  Sunday I was unable to go to church.  I had same symptoms but now very lethargic.  I visited my doctor Monday.  My vitals were good, but I did test positive for COVID-19.  I was prescribed Paxlovid.  Tuesday I was better and did not take it due to kidney issues and by Wednesday I was fine.
Injection site redness; Injection site pain; Injection site itching; Injection site warmth; This case was reported by a consumer via call center representative and described the occurrence of injection site erythema in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On 13th August 2019, the patient received the 1st dose of Shingrix. In August 2019, less than a week after receiving Shingrix, the patient experienced injection site erythema, injection site pain, injection site itching and injection site warmth. On an unknown date, the outcome of the injection site erythema, injection site pain, injection site itching and injection site warmth were unknown.   It was unknown if the reporter considered the injection site erythema, injection site pain, injection site itching and injection site warmth to be related to Shingrix.  Additional information received were as follows: The age at vaccination was not reported. The patient experienced skin redness, measuring 6 by 8 cm. at site of injection which was painful and itchy and warm to touch. With this reaction, the patient asked whether to  take the 2nd dose which would be on 12 October 2019.
Initially site swollen w/a redness around site. Hard to touch. After about 15 hrs, site swollen 2x other leg and red from groin to knee with some hives. This lasted approximately 36 hrs until site went back to slightly swollen and hard. Infant was in no pain or distress. Cried occasionally first night. Benadryl given during course.
2 days post injection, pt c/o hematuria.  and CREATINE PHOSPHOKINASE, TOTAL 347.  The urine was brown within one day.  ON 11/10 creatine phosphokinase total 591 and 11/12 cratine phosphokinase total was 149.  Pt had similiar sxs after second covid vaccine in December but did not have lab testing done.  Continues to have microhematuria
Patient is complaining of lower back pain starting left side & spreading after receiving vaccine. Pt has seen chiropractor & found no relief.
This case was reported by a consumer via call center representative and described the occurrence of influenza-like symptoms in a 55-year-old female patient who received SHINGRIX for prophylaxis. In June 2018, the patient received the 1st dose of SHINGRIX. In June 2018, less than a month after receiving SHINGRIX, the patient experienced influenza-like symptoms, fever, pain in arm, headache, head cold, inability to work and feeling bad. On an unknown date, the outcome of the influenza-like symptoms, fever, pain in arm, headache, head cold, inability to work and feeling bad were unknown. It was unknown if the reporter considered the influenza-like symptoms, fever, pain in arm, headache, head cold, inability to work and feeling bad to be related to SHINGRIX. Additional details were provided as follows: The patient had received the SHINGRIX vaccine 8 days ago. Since that time, the patient had had fevers, arm pain, headaches, general flu type symptoms and at the time of reporting full blown head colds. The patient had missed several days of work, cancelled a hiking trip, and basically felt lousy since the SHINGRIX vaccine was administered with no end in sight. The patient was not sure about that second shot and asked what in the world was in this stuff. This case has been linked with case US2018GSK112843, reported for the patient's husband.
About an hour after shot in my left arm, I began to experience   itchy skin, red bumps on inner elbow on left arm. Now the bumps are discolored and brown/black and I have dark blotch on my inner elbow and the skin is textured
pt recv vax 4APR97 & by Sunday AM 6APR97 pt upper arm was double the size around site of inj;3"x3" area of hot, red, hard tissue post inj the arm (upper rear shoulder) is hard scaly & itchy;no pain today;
experienced hives 4 hours after the administration of the vaccine; as well as nasal congestion; This non-serious case was reported by a physician via call center representative and described the occurrence of hives in a 70-year-old male patient who received Herpes zoster (Shingrix) (batch number 23YG7, expiry date 12-OCT-2023) for prophylaxis.   The patient's past medical history included hives (already being diagnosed with a condition of chronic hives, when he gets sick the hives would get activated). Previously administered products included Zostavax.   On 16-MAR-2023, the patient received the 1st dose of Shingrix. In MAR-2023, 4 hrs after receiving Shingrix, the patient experienced hives (Verbatim: experienced hives 4 hours after the administration of the vaccine) and nasal congestion (Verbatim: as well as nasal congestion). The outcome of the hives and nasal congestion were unknown.   It was unknown if the reporter considered the hives and nasal congestion to be related to Shingrix.     It was unknown if the company considered the hives and nasal congestion to be related to Shingrix.   Additional Information: GSK Receipt Date: 26-JUN-2023 The patient got the Shingrix 1st dose and after 4 hours he did had the hives as he usually got that and he felt his nasal passages were a little closed off but 12 hours after the vaccination. The reporter did not consent to follow-up.